Sign In
Buy SCLX
$7.17
-0.230 (-3.11%)
At Close: Jun 03, 2026
Redesigned website reflects the Company's expanded pipeline of non-opioid pain management products and links to its recent publications and news Redesigned website reflects the Company's expanded pipe
PALO ALTO, Calif., March 02, 2024 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex”), an innovative revenue-generating company focused on acquiring, developing and commercializing
Scilex Holding Company Announces $10 Million Bought Deal Offering
05:32pm, Thursday, 29'th Feb 2024
PALO ALTO, Calif., Feb. 29, 2024 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex” or the “Company”), an innovative revenue-generating company focused on acquiring, developing
PALO ALTO, Calif., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex” or “Company”), an innovative revenue-generating company focused on acquiring, developing and
Penny Stocks To Buy This Week? Analysts Like These 3
04:06pm, Monday, 09'th Oct 2023
Penny stocks are shares of small companies priced under $5 per share. While the potential returns can be alluring, penny stocks carry high risk.
Why Shares of Scilex Are Up Monday
02:55pm, Monday, 09'th Oct 2023
Last week, the company said it is hiring a firm to look into manipulation of its stock. The company just got approval in February from the FDA for acute migraine treatment Elyxyb.
Top 4 Health Care Stocks That Could Lead To Your Biggest Gains In Q3 - Sight Sciences (NASDAQ:SGHT), Scilex Holding (NASDAQ:SCLX)
05:11am, Thursday, 21'st Sep 2023
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
PALO ALTO, Calif., June 16, 2023 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex”), a majority-owned subsidiary of Sorrento Therapeutics, Inc. (OTC: SRNEQ), an innovative revenue
Why Shares of Scilex Slumped This Week
02:42pm, Friday, 28'th Apr 2023
While Scilex is not a debtor in Sorrento Therapuetics' bankruptcy proceedings, it is affected by them. Scilex plans to sell $300 million of stock.
Scilex Holding Company to Participate in the H.C. Wainwright BioConnect Investor Conference at Nasdaq on May 2, 2023
09:00am, Friday, 28'th Apr 2023
PALO ALTO, Calif., April 28, 2023 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex”), a majority-owned subsidiary of Sorrento Therapeutics, Inc. (OTC: SRNEQ), an innovative reven
Scilex (SCLX) Stock Fans, Mark Your Calendars for April 17
09:49am, Thursday, 06'th Apr 2023
Scilex (NASDAQ: SCLX ) stock is plunging 15% after the company delayed its 2023 annual meeting from today until April 17. Scilex, which specializes in developing non-opioid pain treatments, indicated
A SPAC, Spinoff, And Short Squeeze Walk Into A Bar
03:30pm, Tuesday, 24'th Jan 2023
Shares of Scilex could trade higher due to hedging pressure from large Sorrento short positions. Scilex's equity offering facilities, mean that the price could fall precipitously at any time via compa
Why Shares of Scilex Soared This Week
10:24am, Friday, 20'th Jan 2023
Improved revenue estimates and buyout rumors have been driving the stock higher.
